SCHEDULE: SilverArc Capital Management Discloses Fractyl Health Stake

SilverArc Capital Management, LLC and Devesh Gandhi have reported beneficial ownership of 3,606,386 shares, representing 2.3% of Fractyl Health Inc.'s Class A Common Stock as of March 31, 2026.

Summary

• SilverArc Capital Management, LLC and Devesh Gandhi (collectively, the "Reporting Persons") have filed a Schedule 13G, indicating their beneficial ownership of Fractyl Health Inc. Class A Common Stock.
• As of March 31, 2026, the Reporting Persons collectively beneficially own 3,606,386 shares of Class A Common Stock.
• This ownership stake represents 2.3% of the total class of securities.
• The filing indicates shared voting and dispositive power over these shares.
• SilverArc Capital Management, LLC is a Delaware limited liability company, and Devesh Gandhi is a U.S. citizen.
• The securities were acquired and are held in the ordinary course of business and not for the purpose of influencing control of the issuer.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral score as the filing is a routine ownership disclosure and does not provide insights into the company's performance or future prospects.

Positives

• Reporting Persons hold a significant stake (2.3%) in Fractyl Health Inc., indicating investor confidence.
• The filing confirms that the shares were acquired and are held in the ordinary course of business, suggesting a standard investment approach rather than a hostile takeover attempt.

Negatives

• The filing does not contain any negative financial or operational information about Fractyl Health Inc. itself, as it is a disclosure of ownership by an external entity.

Risks

• Potential for increased market activity or volatility if the Reporting Persons decide to increase or decrease their stake significantly.
• The filing does not explicitly mention any risks associated with Fractyl Health Inc.'s business operations or the investment itself.

Future Outlook

The filing does not contain any forward-looking statements or guidance regarding Fractyl Health Inc.'s future performance. It is solely an ownership disclosure.

Management Comments

• "By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11."

Industry Context

StockSavvy.ai notes that Schedule 13G filings are common for institutional investors and significant shareholders to disclose their holdings. This filing indicates a notable investment by SilverArc Capital Management in the biotechnology or healthcare sector, where Fractyl Health Inc. operates.

Stakeholder Impact

• Shareholders: The disclosure may signal continued institutional interest in Fractyl Health Inc., potentially influencing market perception. The 2.3% stake is not large enough to suggest immediate control changes.
• Management: The filing confirms that the investment is not intended to influence control, which may provide some reassurance to current management.
• Creditors/Suppliers: No direct impact is indicated by this ownership disclosure.

Next Steps

• The Reporting Persons will continue to hold their shares in Fractyl Health Inc. in the ordinary course of business.
• Future actions by the Reporting Persons regarding their stake are not detailed in this filing.

Key Dates

Keywords

Fractyl Health Inc., Schedule 13G, SilverArc Capital Management, Devesh Gandhi, Beneficial Ownership, Class A Common Stock, SEC Filing, Investment, Securities Exchange Act